Notably, a recent review article (179) highlighted the direct association between the tumor suppressive effect of exogenous IL-33 and high immunogenic conventional dendritic cells (cDC1s), suggesting that promoting the immunogenicity of DCs with IL-33 may achieve a therapeutic effect. The gene discussed is IL33; the disease is neoplasm.